Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Mitoxantrone for High Risk Prostate Cancer
NCT00003858Phase 2Withdrawn
- Sponsor
- Cancer and Leukemia Group B
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of mitoxantrone in prostate cancer (PCa), sponsored by Cancer and Leukemia Group B. Status: withdrawn.
02
Drugs
mitoxantrone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003858.